Research site

Winckelmann-Apotheke

Germany Wendstrasse 30, 39576 Stendal, Germany

1 trial recruiting
Triple negative breast cancer · Breast cancer stage II · Breast cancer stage I
Adult patients

About Specializations

Winckelmann-Apotheke in Stendal, Germany specialises in clinical trials of conditions such as Triple negative breast cancer, Breast cancer stage II, Breast cancer stage I, Breast cancer female, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Wendstrasse 3039576 StendalGermany

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 5

More sites in Stendal Germany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

1 clinical trial

Triple negative breast cancer+4

Recruiting

Registered drugNo placebo

Study Comparing Sacituzumab Govitecan Alone and with Pembrolizumab for Patients with Low-Risk, Triple-Negative Early Breast Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:WSG Women's Cancer Study Group GmbH

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites